Document is current

Article History

Received: 15 January 2025

Accepted: 24 September 2025

First Online: 13 October 2025

Declarations

:

: Data were evaluated retrospectively after the approval of the local ethics committee of the medical faculty Mannheim, University of Heidelberg, Germany (2018-869R-MA).

: Not applicable.

: Not applicable.

: C.D. reports Varian research grant and travel expenses, AstraZeneca speaker fees and travel expenses, and DGVS speaker fees and travel expenses.D.B. reports personal fees from NB Capital ApS, personal fees from Nordic Biotech, speaker fees from AstraZeneca, outside the submitted work. F.A.G. reports travel expenses, stocks and honoraria from TME Pharma AG; research grants and travel expenses from ELEKTA AB; grants, research grants, travel expenses and honoraria from Carl Zeiss Meditec AG; grants, research grants, travel expenses and honoraria from Biotex, Inc.; travel expenses and research grants from Varian Medical Systems, Inc.; travel expenses and/or honoraria from Bristol-Myers Squibb, Cureteq AG, Roche Pharma AG, MSD Sharp and Dohme GmbH, Siemens Healthineers AG, Varian Medical Systems, and AstraZeneca GmbH; non-financial support from Oncare GmbH and Opasca GmbH and patent US10857388B2 together with Carl Zeiss Meditec AG; all unrelated to this work. L.K. reports AstraZeneca speaker fees.J. B.-H. reports Elekta research grant, EBAMed consulting fees, AstraZeneca speaker fees.All other authors have no competing interests to declare.